Acthar Gel for Chronic Pulmonary Sarcoidosis (ACPS)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
An randomized trial of two maintenance doses of Acthar Gel for patients with chronic pulmonary sarcoidosis. Patients will be observed for 24 weeks of treatment.
Epistemonikos ID: 2459ed45e4e5df5d81788710613e06ce51953b8b
First added on: May 11, 2024